These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26133966)

  • 1. Planning and reporting of quality-of-life outcomes in cancer trials.
    Schandelmaier S; Conen K; von Elm E; You JJ; Blümle A; Tomonaga Y; Amstutz A; Briel M; Kasenda B;
    Ann Oncol; 2015 Sep; 26(9):1966-1973. PubMed ID: 26133966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, characteristics, and publication of discontinued randomized trials.
    Kasenda B; von Elm E; You J; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Meerpohl JJ; Stegert M; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla SM; Mertz D; Akl EA; Bassler D; Busse JW; Ferreira-González I; Lamontagne F; Nordmann A; Gloy V; Raatz H; Moja L; Rosenthal R; Ebrahim S; Schandelmaier S; Xin S; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Hemkens LG; Bucher HC; Guyatt GH; Briel M
    JAMA; 2014 Mar; 311(10):1045-51. PubMed ID: 24618966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.
    Kasenda B; Schandelmaier S; Sun X; von Elm E; You J; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Meerpohl JJ; Stegert M; Olu KK; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla SM; Mertz D; Akl EA; Bassler D; Busse JW; Ferreira-González I; Lamontagne F; Nordmann A; Gloy V; Raatz H; Moja L; Rosenthal R; Ebrahim S; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Hemkens LG; Bucher HC; Guyatt GH; Briel M;
    BMJ; 2014 Jul; 349():g4539. PubMed ID: 25030633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
    Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M
    Ann Oncol; 2018 Dec; 29(12):2288-2295. PubMed ID: 30304498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office.
    Fayers PM; Hopwood P; Harvey A; Girling DJ; Machin D; Stephens R
    Eur J Cancer; 1997 Jan; 33(1):20-8. PubMed ID: 9071894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE).
    Gryaznov D; von Niederhäusern B; Speich B; Kasenda B; Ojeda-Ruiz E; Blümle A; Schandelmaier S; Mertz D; Odutayo A; Tomonaga Y; Amstutz A; Pauli-Magnus C; Gloy V; Lohner S; Bischoff K; Wollmann K; Rehner L; Meerpohl JJ; Nordmann A; Klatte K; Ghosh N; Taji Heravi A; Wong J; Chow N; Hong P; McCord-De Iaco KA; Sricharoenchai S; Busse JW; Agarwal A; Saccilotto R; Schwenkglenks M; Moffa G; Hemkens L; Hopewell S; Von Elm E; Briel M
    BMJ Open; 2022 May; 12(5):e053417. PubMed ID: 35613804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review.
    Weingärtner V; Dargatz N; Weber C; Mueller D; Stock S; Voltz R; Gaertner J
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):821-9. PubMed ID: 26959869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.
    Chan AW; Hróbjartsson A; Jørgensen KJ; Gøtzsche PC; Altman DG
    BMJ; 2008 Dec; 337():a2299. PubMed ID: 19056791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cohort study of trials submitted to ethics committee identified discrepant reporting of outcomes in publications.
    Redmond S; von Elm E; Blümle A; Gengler M; Gsponer T; Egger M
    J Clin Epidemiol; 2013 Dec; 66(12):1367-75. PubMed ID: 24075598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018.
    Marandino L; De Luca E; Zichi C; Lombardi P; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Buttigliero C; Tucci M; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
    Clin Genitourin Cancer; 2019 Oct; 17(5):332-347.e2. PubMed ID: 31416754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).
    Lemieux J; Goodwin PJ; Bordeleau LJ; Lauzier S; Théberge V
    J Natl Cancer Inst; 2011 Feb; 103(3):178-231. PubMed ID: 21217081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Controlled Trials 4: Planning, Analysis, and Interpretation of Quality-of-Life Studies.
    Foley RN; Parfrey PS
    Methods Mol Biol; 2021; 2249():247-259. PubMed ID: 33871848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which health-related quality-of-life outcome when planning randomized trials: disease-specific or generic, or both? A common factor model.
    Ades AE; Lu G; Madan JJ
    Value Health; 2013; 16(1):185-94. PubMed ID: 23337230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis.
    Howell M; Wong G; Turner RM; Tan HT; Tong A; Craig JC; Howard K
    Am J Kidney Dis; 2016 May; 67(5):762-74. PubMed ID: 26724168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications.
    Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M
    J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study).
    Kasenda B; von Elm EB; You J; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Meerpohl J; Stegert M; Tikkinen KA; Neumann I; Carrasco-Labra A; Faulhaber M; Mulla S; Mertz D; Akl EA; Bassler D; Busse JW; Ferreira-González I; Lamontagne F; Nordmann A; Rosenthal R; Schandelmaier S; Sun X; Vandvik PO; Johnston BC; Walter MA; Burnand B; Schwenkglenks M; Bucher HC; Guyatt GH; Briel M
    BMC Med Res Methodol; 2012 Aug; 12():131. PubMed ID: 22928744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC.
    Salomone F; Di Costanzo F; Pecoraro G; Viscardi G; Viggiano A; Napolitano F; Santaniello A; Formisano L; Bianco R; Servetto A
    Lung Cancer; 2022 Dec; 174():36-44. PubMed ID: 36302311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting characteristics of non-primary publications of results of randomized trials: a cross-sectional review.
    Hopewell S; Collins GS; Hirst A; Kirtley S; Tajar A; Gerry S; Altman DG
    Trials; 2013 Jul; 14():240. PubMed ID: 23902608
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.